nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A7—Fluorouracil—stomach cancer	0.219	0.289	CbGbCtD
Cefotaxime—SLC22A7—Docetaxel—stomach cancer	0.167	0.22	CbGbCtD
Cefotaxime—SLC22A11—Methotrexate—stomach cancer	0.127	0.167	CbGbCtD
Cefotaxime—SLC22A7—Methotrexate—stomach cancer	0.121	0.159	CbGbCtD
Cefotaxime—SLC22A8—Methotrexate—stomach cancer	0.0736	0.0972	CbGbCtD
Cefotaxime—SLC22A6—Methotrexate—stomach cancer	0.0513	0.0677	CbGbCtD
Cefotaxime—Colitis—Docetaxel—stomach cancer	0.00116	0.0048	CcSEcCtD
Cefotaxime—Rash—Floxuridine—stomach cancer	0.00116	0.00477	CcSEcCtD
Cefotaxime—Candida infection—Docetaxel—stomach cancer	0.00116	0.00477	CcSEcCtD
Cefotaxime—Dermatitis—Floxuridine—stomach cancer	0.00116	0.00477	CcSEcCtD
Cefotaxime—Headache—Floxuridine—stomach cancer	0.00115	0.00474	CcSEcCtD
Cefotaxime—Body temperature increased—Mitomycin—stomach cancer	0.00114	0.0047	CcSEcCtD
Cefotaxime—Colitis—Capecitabine—stomach cancer	0.00113	0.00465	CcSEcCtD
Cefotaxime—Candida infection—Capecitabine—stomach cancer	0.00112	0.00462	CcSEcCtD
Cefotaxime—Nausea—Floxuridine—stomach cancer	0.00109	0.0045	CcSEcCtD
Cefotaxime—Eosinophilia—Fluorouracil—stomach cancer	0.00104	0.0043	CcSEcCtD
Cefotaxime—Neutropenia—Irinotecan—stomach cancer	0.00103	0.00424	CcSEcCtD
Cefotaxime—Diarrhoea—Mitomycin—stomach cancer	0.000985	0.00406	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Capecitabine—stomach cancer	0.000974	0.00402	CcSEcCtD
Cefotaxime—Liver injury—Epirubicin—stomach cancer	0.000971	0.00401	CcSEcCtD
Cefotaxime—Renal failure—Irinotecan—stomach cancer	0.000964	0.00398	CcSEcCtD
Cefotaxime—Jaundice—Irinotecan—stomach cancer	0.000956	0.00394	CcSEcCtD
Cefotaxime—Haemolytic anaemia—Capecitabine—stomach cancer	0.000943	0.00389	CcSEcCtD
Cefotaxime—Renal impairment—Docetaxel—stomach cancer	0.000924	0.00381	CcSEcCtD
Cefotaxime—Dermatitis bullous—Docetaxel—stomach cancer	0.00092	0.0038	CcSEcCtD
Cefotaxime—Vomiting—Mitomycin—stomach cancer	0.000915	0.00378	CcSEcCtD
Cefotaxime—Rash—Mitomycin—stomach cancer	0.000908	0.00374	CcSEcCtD
Cefotaxime—Dermatitis—Mitomycin—stomach cancer	0.000907	0.00374	CcSEcCtD
Cefotaxime—Headache—Mitomycin—stomach cancer	0.000902	0.00372	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—stomach cancer	0.000899	0.00371	CcSEcCtD
Cefotaxime—Renal impairment—Capecitabine—stomach cancer	0.000895	0.00369	CcSEcCtD
Cefotaxime—Dermatitis bullous—Capecitabine—stomach cancer	0.000891	0.00368	CcSEcCtD
Cefotaxime—Haemoglobin—Irinotecan—stomach cancer	0.000885	0.00365	CcSEcCtD
Cefotaxime—Haemorrhage—Irinotecan—stomach cancer	0.00088	0.00363	CcSEcCtD
Cefotaxime—Agranulocytosis—Fluorouracil—stomach cancer	0.000876	0.00361	CcSEcCtD
Cefotaxime—Vaginal inflammation—Methotrexate—stomach cancer	0.000873	0.0036	CcSEcCtD
Cefotaxime—Nausea—Mitomycin—stomach cancer	0.000855	0.00353	CcSEcCtD
Cefotaxime—Haemoglobin—Fluorouracil—stomach cancer	0.000847	0.00349	CcSEcCtD
Cefotaxime—Haemorrhage—Fluorouracil—stomach cancer	0.000843	0.00348	CcSEcCtD
Cefotaxime—Vaginal infection—Methotrexate—stomach cancer	0.000824	0.0034	CcSEcCtD
Cefotaxime—Aplastic anaemia—Methotrexate—stomach cancer	0.00082	0.00338	CcSEcCtD
Cefotaxime—Vaginal inflammation—Epirubicin—stomach cancer	0.000817	0.00337	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.000792	0.00327	CcSEcCtD
Cefotaxime—Arrhythmia—Irinotecan—stomach cancer	0.000786	0.00324	CcSEcCtD
Cefotaxime—Colitis—Epirubicin—stomach cancer	0.000785	0.00324	CcSEcCtD
Cefotaxime—Candida infection—Epirubicin—stomach cancer	0.00078	0.00322	CcSEcCtD
Cefotaxime—Vaginal infection—Epirubicin—stomach cancer	0.000772	0.00318	CcSEcCtD
Cefotaxime—Aplastic anaemia—Epirubicin—stomach cancer	0.000767	0.00316	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.000767	0.00316	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—stomach cancer	0.000756	0.00312	CcSEcCtD
Cefotaxime—Arrhythmia—Fluorouracil—stomach cancer	0.000753	0.00311	CcSEcCtD
Cefotaxime—Bronchospasm—Docetaxel—stomach cancer	0.000748	0.00308	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—stomach cancer	0.000726	0.00299	CcSEcCtD
Cefotaxime—Bronchospasm—Capecitabine—stomach cancer	0.000724	0.00299	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—stomach cancer	0.000722	0.00298	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—stomach cancer	0.000714	0.00294	CcSEcCtD
Cefotaxime—Ill-defined disorder—Irinotecan—stomach cancer	0.000711	0.00293	CcSEcCtD
Cefotaxime—Neutropenia—Docetaxel—stomach cancer	0.000711	0.00293	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—stomach cancer	0.00071	0.00293	CcSEcCtD
Cefotaxime—Malaise—Irinotecan—stomach cancer	0.000691	0.00285	CcSEcCtD
Cefotaxime—Neutropenia—Capecitabine—stomach cancer	0.000688	0.00284	CcSEcCtD
Cefotaxime—Leukopenia—Irinotecan—stomach cancer	0.000686	0.00283	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Epirubicin—stomach cancer	0.000679	0.0028	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000672	0.00277	CcSEcCtD
Cefotaxime—Renal failure—Docetaxel—stomach cancer	0.000666	0.00275	CcSEcCtD
Cefotaxime—Jaundice—Docetaxel—stomach cancer	0.000661	0.00273	CcSEcCtD
Cefotaxime—Leukopenia—Fluorouracil—stomach cancer	0.000657	0.00271	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000651	0.00268	CcSEcCtD
Cefotaxime—Renal failure—Capecitabine—stomach cancer	0.000645	0.00266	CcSEcCtD
Cefotaxime—Discomfort—Irinotecan—stomach cancer	0.000644	0.00266	CcSEcCtD
Cefotaxime—Jaundice—Capecitabine—stomach cancer	0.00064	0.00264	CcSEcCtD
Cefotaxime—Convulsion—Fluorouracil—stomach cancer	0.000636	0.00262	CcSEcCtD
Cefotaxime—Agranulocytosis—Docetaxel—stomach cancer	0.000632	0.00261	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—stomach cancer	0.000628	0.00259	CcSEcCtD
Cefotaxime—Anaphylactic shock—Irinotecan—stomach cancer	0.000625	0.00258	CcSEcCtD
Cefotaxime—Renal impairment—Epirubicin—stomach cancer	0.000623	0.00257	CcSEcCtD
Cefotaxime—Dermatitis bullous—Epirubicin—stomach cancer	0.000621	0.00256	CcSEcCtD
Cefotaxime—Discomfort—Fluorouracil—stomach cancer	0.000617	0.00255	CcSEcCtD
Cefotaxime—Shock—Irinotecan—stomach cancer	0.000615	0.00254	CcSEcCtD
Cefotaxime—Agranulocytosis—Capecitabine—stomach cancer	0.000612	0.00253	CcSEcCtD
Cefotaxime—Thrombocytopenia—Irinotecan—stomach cancer	0.000612	0.00253	CcSEcCtD
Cefotaxime—Haemoglobin—Docetaxel—stomach cancer	0.000612	0.00252	CcSEcCtD
Cefotaxime—Haemorrhage—Docetaxel—stomach cancer	0.000608	0.00251	CcSEcCtD
Cefotaxime—Hepatitis—Docetaxel—stomach cancer	0.000608	0.00251	CcSEcCtD
Cefotaxime—Anaphylactic shock—Fluorouracil—stomach cancer	0.000599	0.00247	CcSEcCtD
Cefotaxime—Haemoglobin—Capecitabine—stomach cancer	0.000592	0.00244	CcSEcCtD
Cefotaxime—Haemorrhage—Capecitabine—stomach cancer	0.000589	0.00243	CcSEcCtD
Cefotaxime—Hepatitis—Capecitabine—stomach cancer	0.000589	0.00243	CcSEcCtD
Cefotaxime—Thrombocytopenia—Fluorouracil—stomach cancer	0.000586	0.00242	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—stomach cancer	0.000577	0.00238	CcSEcCtD
Cefotaxime—Erythema multiforme—Docetaxel—stomach cancer	0.000575	0.00237	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—stomach cancer	0.000574	0.00237	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000571	0.00235	CcSEcCtD
Cefotaxime—Erythema multiforme—Capecitabine—stomach cancer	0.000557	0.0023	CcSEcCtD
Cefotaxime—Arrhythmia—Docetaxel—stomach cancer	0.000544	0.00224	CcSEcCtD
Cefotaxime—Eosinophilia—Methotrexate—stomach cancer	0.000542	0.00224	CcSEcCtD
Cefotaxime—Pain—Irinotecan—stomach cancer	0.000535	0.00221	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000534	0.0022	CcSEcCtD
Cefotaxime—Arrhythmia—Capecitabine—stomach cancer	0.000526	0.00217	CcSEcCtD
Cefotaxime—Feeling abnormal—Irinotecan—stomach cancer	0.000515	0.00213	CcSEcCtD
Cefotaxime—Neutropenia—Methotrexate—stomach cancer	0.000512	0.00211	CcSEcCtD
Cefotaxime—Pain—Fluorouracil—stomach cancer	0.000512	0.00211	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Irinotecan—stomach cancer	0.000511	0.00211	CcSEcCtD
Cefotaxime—Eosinophilia—Epirubicin—stomach cancer	0.000508	0.00209	CcSEcCtD
Cefotaxime—Abdominal pain—Irinotecan—stomach cancer	0.000494	0.00204	CcSEcCtD
Cefotaxime—Body temperature increased—Irinotecan—stomach cancer	0.000494	0.00204	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000494	0.00204	CcSEcCtD
Cefotaxime—Feeling abnormal—Fluorouracil—stomach cancer	0.000494	0.00204	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000484	0.002	CcSEcCtD
Cefotaxime—Renal failure—Methotrexate—stomach cancer	0.00048	0.00198	CcSEcCtD
Cefotaxime—Neutropenia—Epirubicin—stomach cancer	0.000479	0.00198	CcSEcCtD
Cefotaxime—Ill-defined disorder—Capecitabine—stomach cancer	0.000476	0.00196	CcSEcCtD
Cefotaxime—Urticaria—Fluorouracil—stomach cancer	0.000476	0.00196	CcSEcCtD
Cefotaxime—Leukopenia—Docetaxel—stomach cancer	0.000474	0.00196	CcSEcCtD
Cefotaxime—Body temperature increased—Fluorouracil—stomach cancer	0.000473	0.00195	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—stomach cancer	0.00047	0.00194	CcSEcCtD
Cefotaxime—Malaise—Capecitabine—stomach cancer	0.000462	0.00191	CcSEcCtD
Cefotaxime—Hypersensitivity—Irinotecan—stomach cancer	0.000461	0.0019	CcSEcCtD
Cefotaxime—Leukopenia—Capecitabine—stomach cancer	0.000459	0.00189	CcSEcCtD
Cefotaxime—Convulsion—Docetaxel—stomach cancer	0.000459	0.00189	CcSEcCtD
Cefotaxime—Agranulocytosis—Methotrexate—stomach cancer	0.000456	0.00188	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000453	0.00187	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—stomach cancer	0.000449	0.00185	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—stomach cancer	0.000446	0.00184	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—stomach cancer	0.000444	0.00183	CcSEcCtD
Cefotaxime—Hypersensitivity—Fluorouracil—stomach cancer	0.000441	0.00182	CcSEcCtD
Cefotaxime—Haemoglobin—Methotrexate—stomach cancer	0.000441	0.00182	CcSEcCtD
Cefotaxime—Haemorrhage—Methotrexate—stomach cancer	0.000439	0.00181	CcSEcCtD
Cefotaxime—Hepatitis—Methotrexate—stomach cancer	0.000439	0.00181	CcSEcCtD
Cefotaxime—Anaphylactic shock—Docetaxel—stomach cancer	0.000432	0.00178	CcSEcCtD
Cefotaxime—Discomfort—Capecitabine—stomach cancer	0.000431	0.00178	CcSEcCtD
Cefotaxime—Diarrhoea—Irinotecan—stomach cancer	0.000428	0.00176	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—stomach cancer	0.000427	0.00176	CcSEcCtD
Cefotaxime—Shock—Docetaxel—stomach cancer	0.000425	0.00175	CcSEcCtD
Cefotaxime—Pruritus—Fluorouracil—stomach cancer	0.000424	0.00175	CcSEcCtD
Cefotaxime—Thrombocytopenia—Docetaxel—stomach cancer	0.000423	0.00175	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000419	0.00173	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—stomach cancer	0.000416	0.00172	CcSEcCtD
Cefotaxime—Erythema multiforme—Methotrexate—stomach cancer	0.000415	0.00171	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—stomach cancer	0.000412	0.0017	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—stomach cancer	0.000412	0.0017	CcSEcCtD
Cefotaxime—Shock—Capecitabine—stomach cancer	0.000412	0.0017	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—stomach cancer	0.00041	0.00169	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—stomach cancer	0.00041	0.00169	CcSEcCtD
Cefotaxime—Diarrhoea—Fluorouracil—stomach cancer	0.00041	0.00169	CcSEcCtD
Cefotaxime—Thrombocytopenia—Capecitabine—stomach cancer	0.00041	0.00169	CcSEcCtD
Cefotaxime—Vomiting—Irinotecan—stomach cancer	0.000398	0.00164	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—stomach cancer	0.000395	0.00163	CcSEcCtD
Cefotaxime—Rash—Irinotecan—stomach cancer	0.000394	0.00163	CcSEcCtD
Cefotaxime—Dermatitis—Irinotecan—stomach cancer	0.000394	0.00162	CcSEcCtD
Cefotaxime—Headache—Irinotecan—stomach cancer	0.000392	0.00162	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—stomach cancer	0.000388	0.0016	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—stomach cancer	0.000382	0.00157	CcSEcCtD
Cefotaxime—Vomiting—Fluorouracil—stomach cancer	0.000381	0.00157	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—stomach cancer	0.00038	0.00157	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—stomach cancer	0.00038	0.00157	CcSEcCtD
Cefotaxime—Rash—Fluorouracil—stomach cancer	0.000378	0.00156	CcSEcCtD
Cefotaxime—Dermatitis—Fluorouracil—stomach cancer	0.000377	0.00156	CcSEcCtD
Cefotaxime—Headache—Fluorouracil—stomach cancer	0.000375	0.00155	CcSEcCtD
Cefotaxime—Nausea—Irinotecan—stomach cancer	0.000371	0.00153	CcSEcCtD
Cefotaxime—Pain—Docetaxel—stomach cancer	0.00037	0.00152	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—stomach cancer	0.000367	0.00151	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—stomach cancer	0.000359	0.00148	CcSEcCtD
Cefotaxime—Pain—Capecitabine—stomach cancer	0.000358	0.00148	CcSEcCtD
Cefotaxime—Feeling abnormal—Docetaxel—stomach cancer	0.000356	0.00147	CcSEcCtD
Cefotaxime—Nausea—Fluorouracil—stomach cancer	0.000356	0.00147	CcSEcCtD
Cefotaxime—Ill-defined disorder—Methotrexate—stomach cancer	0.000354	0.00146	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Docetaxel—stomach cancer	0.000353	0.00146	CcSEcCtD
Cefotaxime—Feeling abnormal—Capecitabine—stomach cancer	0.000345	0.00142	CcSEcCtD
Cefotaxime—Malaise—Methotrexate—stomach cancer	0.000344	0.00142	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Capecitabine—stomach cancer	0.000342	0.00141	CcSEcCtD
Cefotaxime—Body temperature increased—Docetaxel—stomach cancer	0.000342	0.00141	CcSEcCtD
Cefotaxime—Abdominal pain—Docetaxel—stomach cancer	0.000342	0.00141	CcSEcCtD
Cefotaxime—Leukopenia—Methotrexate—stomach cancer	0.000342	0.00141	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—stomach cancer	0.000339	0.0014	CcSEcCtD
Cefotaxime—Urticaria—Capecitabine—stomach cancer	0.000332	0.00137	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—stomach cancer	0.000331	0.00137	CcSEcCtD
Cefotaxime—Abdominal pain—Capecitabine—stomach cancer	0.000331	0.00136	CcSEcCtD
Cefotaxime—Body temperature increased—Capecitabine—stomach cancer	0.000331	0.00136	CcSEcCtD
Cefotaxime—Convulsion—Methotrexate—stomach cancer	0.000331	0.00136	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—stomach cancer	0.000322	0.00133	CcSEcCtD
Cefotaxime—Discomfort—Methotrexate—stomach cancer	0.000321	0.00132	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—stomach cancer	0.00032	0.00132	CcSEcCtD
Cefotaxime—Hypersensitivity—Docetaxel—stomach cancer	0.000318	0.00131	CcSEcCtD
Cefotaxime—Anaphylactic shock—Methotrexate—stomach cancer	0.000312	0.00129	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—stomach cancer	0.00031	0.00128	CcSEcCtD
Cefotaxime—Hypersensitivity—Capecitabine—stomach cancer	0.000308	0.00127	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—stomach cancer	0.000307	0.00127	CcSEcCtD
Cefotaxime—Pruritus—Docetaxel—stomach cancer	0.000306	0.00126	CcSEcCtD
Cefotaxime—Thrombocytopenia—Methotrexate—stomach cancer	0.000305	0.00126	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—stomach cancer	0.000301	0.00124	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—stomach cancer	0.000298	0.00123	CcSEcCtD
Cefotaxime—Pruritus—Capecitabine—stomach cancer	0.000296	0.00122	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—stomach cancer	0.000296	0.00122	CcSEcCtD
Cefotaxime—Diarrhoea—Docetaxel—stomach cancer	0.000296	0.00122	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—stomach cancer	0.000292	0.0012	CcSEcCtD
Cefotaxime—Shock—Epirubicin—stomach cancer	0.000287	0.00118	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—stomach cancer	0.000286	0.00118	CcSEcCtD
Cefotaxime—Diarrhoea—Capecitabine—stomach cancer	0.000286	0.00118	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—stomach cancer	0.000285	0.00118	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—stomach cancer	0.000278	0.00115	CcSEcCtD
Cefotaxime—Vomiting—Docetaxel—stomach cancer	0.000275	0.00113	CcSEcCtD
Cefotaxime—Rash—Docetaxel—stomach cancer	0.000273	0.00112	CcSEcCtD
Cefotaxime—Dermatitis—Docetaxel—stomach cancer	0.000272	0.00112	CcSEcCtD
Cefotaxime—Headache—Docetaxel—stomach cancer	0.000271	0.00112	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—stomach cancer	0.00027	0.00111	CcSEcCtD
Cefotaxime—Pain—Methotrexate—stomach cancer	0.000266	0.0011	CcSEcCtD
Cefotaxime—Vomiting—Capecitabine—stomach cancer	0.000266	0.0011	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—stomach cancer	0.000265	0.00109	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—stomach cancer	0.000264	0.00109	CcSEcCtD
Cefotaxime—Rash—Capecitabine—stomach cancer	0.000264	0.00109	CcSEcCtD
Cefotaxime—Dermatitis—Capecitabine—stomach cancer	0.000264	0.00109	CcSEcCtD
Cefotaxime—Headache—Capecitabine—stomach cancer	0.000262	0.00108	CcSEcCtD
Cefotaxime—Nausea—Docetaxel—stomach cancer	0.000257	0.00106	CcSEcCtD
Cefotaxime—Feeling abnormal—Methotrexate—stomach cancer	0.000257	0.00106	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Methotrexate—stomach cancer	0.000255	0.00105	CcSEcCtD
Cefotaxime—Pain—Epirubicin—stomach cancer	0.000249	0.00103	CcSEcCtD
Cefotaxime—Nausea—Capecitabine—stomach cancer	0.000249	0.00103	CcSEcCtD
Cefotaxime—Urticaria—Methotrexate—stomach cancer	0.000248	0.00102	CcSEcCtD
Cefotaxime—Abdominal pain—Methotrexate—stomach cancer	0.000246	0.00102	CcSEcCtD
Cefotaxime—Body temperature increased—Methotrexate—stomach cancer	0.000246	0.00102	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—stomach cancer	0.00024	0.000991	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—stomach cancer	0.000238	0.000983	CcSEcCtD
Cefotaxime—Urticaria—Epirubicin—stomach cancer	0.000232	0.000955	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—stomach cancer	0.000231	0.000952	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—stomach cancer	0.00023	0.000951	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—stomach cancer	0.00023	0.000951	CcSEcCtD
Cefotaxime—Hypersensitivity—Methotrexate—stomach cancer	0.00023	0.000947	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—stomach cancer	0.000222	0.000917	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000221	0.00091	CcSEcCtD
Cefotaxime—Pruritus—Methotrexate—stomach cancer	0.00022	0.000909	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—stomach cancer	0.000215	0.000886	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—stomach cancer	0.000214	0.000884	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—stomach cancer	0.000213	0.00088	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—stomach cancer	0.000213	0.00088	CcSEcCtD
Cefotaxime—Diarrhoea—Methotrexate—stomach cancer	0.000213	0.000879	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—stomach cancer	0.000206	0.000851	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—stomach cancer	0.000199	0.000823	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—stomach cancer	0.000199	0.00082	CcSEcCtD
Cefotaxime—Vomiting—Methotrexate—stomach cancer	0.000198	0.000817	CcSEcCtD
Cefotaxime—Rash—Methotrexate—stomach cancer	0.000196	0.00081	CcSEcCtD
Cefotaxime—Dermatitis—Methotrexate—stomach cancer	0.000196	0.00081	CcSEcCtD
Cefotaxime—Headache—Methotrexate—stomach cancer	0.000195	0.000805	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—stomach cancer	0.000191	0.000787	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—stomach cancer	0.000185	0.000765	CcSEcCtD
Cefotaxime—Nausea—Methotrexate—stomach cancer	0.000185	0.000763	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—stomach cancer	0.000185	0.000761	CcSEcCtD
Cefotaxime—Rash—Epirubicin—stomach cancer	0.000184	0.000758	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—stomach cancer	0.000184	0.000758	CcSEcCtD
Cefotaxime—Headache—Epirubicin—stomach cancer	0.000183	0.000753	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—stomach cancer	0.000173	0.000714	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—stomach cancer	0.000172	0.000708	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—stomach cancer	0.00017	0.000702	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—stomach cancer	0.00017	0.000701	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—stomach cancer	0.000169	0.000697	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—stomach cancer	0.00016	0.000661	CcSEcCtD
